LL 35 (Endacof tab guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg)
Generic Name: guaifenesin/hydrocodone
Pill imprint LL 35 has been identified as Endacof tab guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg.
EndaCof-Tab is used in the treatment of cough and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. EndaCof-Tab guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- LL 35
- guaifenesin 300 mg / hydrocodone bitartrate 2.5 mg
- Prescription only
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Larken Laboratories, Inc.
More about EndaCof-Tab (guaifenesin / hydrocodone)
- Side Effects
- During Pregnancy
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: upper respiratory combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.